There’s an intersection between secondary infections and AMR that some have been pointing out e.g. https://sciencespeaksblog.org/2020/04/06/covid-19-role-of-superinfections-in-novel-coronavirus-deaths-highlights-urgent-need-for-sustainable-development-of-new-antibiotics/ and usage is high in COVID-19 patients from demographic studies and CAP guidance in the UK is to use co-amoxiclav plus a macrolide (mostly azithromycin it seems). Any evidence of increased AMR?
A nice collection of AMR and COVID-19 publications from Issra Bulgasim at Liverpool School for Tropical Medicine.
Interesting perspective here:
Call for stewardship to not be abandoned in AMR. Includes reiteration of the point that we don’t know what infections there are out there.
Article for GARDP by Andrew Seaton on AMR stewardship in COVID-19